Università di Parma.
Unità di Neuroradiologia, Azienda Ospedaliera-Universitaria di Parma.
Acta Biomed. 2020 May 11;91(2):365-372. doi: 10.23750/abm.v91i2.8685.
Posterior reversible encephalopathy (PRES) is a rare syndrome characterized by headache, confusion, seizures, visual changes and white matter edema at radiological imaging. Its pathophysiology is not clarified and different causes, including uncontrolled hypertension, eclampsia, chemotherapy and hypomagnesemia have been suggested.
A woman affected by stage IV breast cancer with lower extremity deep vein thrombosis treated with low-molecular-weight-heparin, currently in therapy with Palbociclib/Fulvestrant (antiCDK4 and 6/estrogen receptor antagonist) but previously treated with several other chemotherapy lines (including VEGF inhibitor bevacizumab), was admitted to our Internal Medicine department because of ascites and abdominal pain. She was treated with diuretics (and paracentesis). Recently (six-month earlier) a pan-encephalic radiotherapy was done because of brain and skull metastasis. Among blood tests, low serum levels of hypomagnesemia were observed. She developed PRES that rapidly progressed to lethargy, unresponsiveness till coma without changes in blood pressure. Magnetic Resonance Imaging study showed bilateral parieto-occipital edema and a thrombosis of left transverse and sigmoid sinuses. Anti-edema therapy, intravenous supplementation of magnesium and decoagulation were started, with complete and rapid recovery (within 18 hours) of clinical and radiologic changes.
PRES diagnosis was based on the rapid clinical recovery after antiedema treatment and magnesium supplementation. Low magnesium level related to both diuretic and Fulvestrant/Palbociclib therapies and recent radiotherapy can represent potential mechanisms favouring PRES development. The previous bevacizumab treatment may also be involved as a PRES predisposing factor. The concomitant occurrence of cerebral thrombosis can have precipitated the clinical situation.
后部可逆性脑病综合征(PRES)是一种罕见的综合征,其特征为头痛、意识模糊、癫痫发作、视力改变和影像学检查的白质水肿。其病理生理学尚未阐明,不同的病因,包括未控制的高血压、子痫、化疗和低镁血症等,都有被提出。
一位患有 IV 期乳腺癌的女性,下肢深静脉血栓形成,接受低分子肝素治疗,目前正在接受 Palbociclib/Fulvestrant(抗 CDK4 和 6/雌激素受体拮抗剂)治疗,但之前曾接受过其他几种化疗方案(包括 VEGF 抑制剂贝伐珠单抗)。因腹水和腹痛收入我院内科。她接受了利尿剂(和腹腔穿刺术)治疗。最近(六个月前)因脑和颅骨转移进行了全脑放疗。在血液检查中,观察到低血清镁血症。她发生了 PRES,迅速进展为昏睡、无反应直至昏迷,血压无变化。磁共振成像研究显示双侧顶枕叶水肿和左侧横窦和乙状窦血栓形成。开始进行抗水肿治疗、静脉补充镁和抗凝治疗,临床和影像学变化在 18 小时内完全和迅速恢复。
PRES 的诊断基于抗水肿治疗和镁补充后的快速临床恢复。利尿剂和 Fulvestrant/Palbociclib 治疗以及最近的放疗引起的低镁血症可能是 PRES 发展的潜在机制。之前的贝伐珠单抗治疗也可能是 PRES 的诱发因素。同时发生的脑血栓形成可能导致了临床情况的恶化。